Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
Endogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remain...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/full |
_version_ | 1818643708601434112 |
---|---|
author | Xin Chen Xin Chen Bo-lun Shi Run-zhi Qi Xing Chang Xing Chang Hong-gang Zheng Hong-gang Zheng Hong-gang Zheng |
author_facet | Xin Chen Xin Chen Bo-lun Shi Run-zhi Qi Xing Chang Xing Chang Hong-gang Zheng Hong-gang Zheng Hong-gang Zheng |
author_sort | Xin Chen |
collection | DOAJ |
description | Endogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remains unclear. In the present study, we investigated the therapeutic effects and the underlying molecular mechanisms of HNK on colorectal cancer in a mouse model (ApcMin/+) by analyzing the urine metabolic profile based on metabolomics, which is a powerful tool for characterizing metabolic disturbances. We found that potential urine biomarkers were involved in the metabolism of compounds such as purines, tyrosines, tryptophans, etc. Moreover, we showed that a total of 27 metabolites were the most contribution biomarkers for intestinal tumors, and we found that the citrate cycle (TCA cycle) was regulated by HNK. In addition, it was suggested that the efficacy of HNK was achieved by affecting the multi-pathway system via influencing relevant metabolic pathways and regulating metabolic function. Our work also showed that high-throughput metabolomics can characterize the regulation of metabolic disorders as a therapeutic strategy to prevent colorectal cancer. |
first_indexed | 2024-12-17T00:03:15Z |
format | Article |
id | doaj.art-af65a929c57540aa94f5da7a89175f53 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-17T00:03:15Z |
publishDate | 2021-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-af65a929c57540aa94f5da7a89175f532022-12-21T22:11:01ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.671014671014Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of HonokiolXin Chen0Xin Chen1Bo-lun Shi2Run-zhi Qi3Xing Chang4Xing Chang5Hong-gang Zheng6Hong-gang Zheng7Hong-gang Zheng8Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaChina Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaChina Academy of Chinese Medical Sciences, Beijing, ChinaGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaEndogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remains unclear. In the present study, we investigated the therapeutic effects and the underlying molecular mechanisms of HNK on colorectal cancer in a mouse model (ApcMin/+) by analyzing the urine metabolic profile based on metabolomics, which is a powerful tool for characterizing metabolic disturbances. We found that potential urine biomarkers were involved in the metabolism of compounds such as purines, tyrosines, tryptophans, etc. Moreover, we showed that a total of 27 metabolites were the most contribution biomarkers for intestinal tumors, and we found that the citrate cycle (TCA cycle) was regulated by HNK. In addition, it was suggested that the efficacy of HNK was achieved by affecting the multi-pathway system via influencing relevant metabolic pathways and regulating metabolic function. Our work also showed that high-throughput metabolomics can characterize the regulation of metabolic disorders as a therapeutic strategy to prevent colorectal cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/fullmetabolomicsbiomarkersmetabolitesultra-performance liquid chromatographymass spectrometry |
spellingShingle | Xin Chen Xin Chen Bo-lun Shi Run-zhi Qi Xing Chang Xing Chang Hong-gang Zheng Hong-gang Zheng Hong-gang Zheng Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol Frontiers in Oncology metabolomics biomarkers metabolites ultra-performance liquid chromatography mass spectrometry |
title | Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol |
title_full | Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol |
title_fullStr | Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol |
title_full_unstemmed | Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol |
title_short | Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol |
title_sort | ultra performance liquid chromatography mass spectrometry based metabolomics for discovering potential biomarkers and metabolic pathways of colorectal cancer in mouse model apcmin and revealing the effect of honokiol |
topic | metabolomics biomarkers metabolites ultra-performance liquid chromatography mass spectrometry |
url | https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/full |
work_keys_str_mv | AT xinchen ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT xinchen ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT bolunshi ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT runzhiqi ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT xingchang ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT xingchang ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol |